These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 35631358)
1. Covalent Inhibition of the Serrano-Aparicio N; Ferrer S; Świderek K Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631358 [TBL] [Abstract][Full Text] [Related]
2. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin. Serrano-Aparicio N; Świderek K; Moliner V Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit. Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic and thermodynamic characterization of oxathiazolones as potent and selective covalent immunoproteasome inhibitors. Mihalovits LM; Ferenczy GG; Keserű GM Comput Struct Biotechnol J; 2021; 19():4486-4496. PubMed ID: 34471494 [TBL] [Abstract][Full Text] [Related]
5. Identification of a new series of amides as non-covalent proteasome inhibitors. Scarbaci K; Troiano V; Micale N; Ettari R; Tamborini L; Di Giovanni C; Cerchia C; Grasso S; Novellino E; Schirmeister T; Lavecchia A; Zappalà M Eur J Med Chem; 2014 Apr; 76():1-9. PubMed ID: 24561716 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome. Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024 [TBL] [Abstract][Full Text] [Related]
7. Elucidation of the Zhou J; Sang X; Wang J; Xu Y; An J; Chu ZT; Saha A; Warshel A; Huang Z ACS Catal; 2023 Nov; 13(21):14368-14376. PubMed ID: 39188993 [TBL] [Abstract][Full Text] [Related]
8. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes. Grover A; Shandilya A; Bisaria VS; Sundar D BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798 [TBL] [Abstract][Full Text] [Related]
9. Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome. Arba M; Nur-Hidayat A; Ruslin ; Yusuf M; Sumarlin ; Hertadi R; Wahyudi ST; Surantaadmaja SI; Tjahjono DH Comput Biol Chem; 2018 Jun; 74():230-238. PubMed ID: 29674291 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Groll M; Huber R Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807 [TBL] [Abstract][Full Text] [Related]
11. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol. Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842 [TBL] [Abstract][Full Text] [Related]
12. Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome. Arba M; Nur-Hidayat A; Surantaadmaja SI; Tjahjono DH Comput Biol Chem; 2018 Dec; 77():64-71. PubMed ID: 30243108 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations. Li A; Sun H; Du L; Wu X; Cao J; You Q; Li Y J Mol Model; 2014 Nov; 20(11):2515. PubMed ID: 25394401 [TBL] [Abstract][Full Text] [Related]
14. Proteasome structure, function, and lessons learned from beta-lactone inhibitors. Groll M; Potts BC Curr Top Med Chem; 2011 Dec; 11(23):2850-78. PubMed ID: 21824111 [TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone. McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040 [TBL] [Abstract][Full Text] [Related]
16. Quantum mechanics/molecular mechanics minimum free-energy path for accurate reaction energetics in solution and enzymes: sequential sampling and optimization on the potential of mean force surface. Hu H; Lu Z; Parks JM; Burger SK; Yang W J Chem Phys; 2008 Jan; 128(3):034105. PubMed ID: 18205486 [TBL] [Abstract][Full Text] [Related]
17. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease. Awoonor-Williams E; Abu-Saleh AAA Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090 [TBL] [Abstract][Full Text] [Related]